Recent Updates
Recently added Catalysts
AZTR

Azitra to Present at the Biotech Showcase Annual Conference on January 8, 2018

Key Takeaway: FARMINGTON, CT, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Azitra Inc. today announced that Richard Andrews, President and Chief Executive Officer, is scheduled to present at Biotech Showcase™ 2018 taking place on January 8-10, 2018 at the Hilton San Francisco Union Square, San Francisco,

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~6 mo
High dilution risk
Lead asset
ATR04-484
Phase 1 · EGFR Inhibitor-associated Rash

Full Press Release Details

FARMINGTON, CT, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Azitra Inc. today announced that Richard Andrews, President and Chief Executive Officer, is scheduled to present at Biotech Showcase™ 2018 taking place on January 8-10, 2018 at the Hilton San Francisco Union Square, San Francisco, CA. Azitra is focused on treating skin disease by combining the potential of the microbiome with state of the art molecular genetics.
Details for the presentation are as follows:
Date: January 8, 2018
Room: Hilton/Franciscan C, Ballroom Level
Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA
A webcast will be archived shortly after the live event and will be available through the Azitra website at https://azitrainc.com/events/.
Azitra, Inc. is a preclinical stage biotechnology company harnessing the power of the microbiome to treat skin disease. The Company was founded in 2014 by scientists from Yale University and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its programs in atopic dermatitis and targeted orphan indications. For more information visit www.azitrainc.com.
Last updated: Jan 3, 2018